Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
beta blocker |
| gptkbp:approvalYear |
1986
|
| gptkbp:ATCCode |
C07AB09
|
| gptkbp:brand |
Brevibloc
|
| gptkbp:CASNumber |
81147-92-4
|
| gptkbp:chemicalFormula |
C16H25NO4
|
| gptkbp:contraindication |
heart block
severe bradycardia cardiogenic shock |
| gptkbp:discoveredBy |
gptkb:David_T._Wong
|
| gptkbp:eliminationHalfLife |
9 minutes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Esmolol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
beta-1 adrenergic receptor antagonist
|
| gptkbp:metabolism |
plasma esterases
|
| gptkbp:molecularWeight |
295.37 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:proteinBinding |
55%
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
fatigue hypotension bradycardia |
| gptkbp:usedFor |
gptkb:atrial_fibrillation
gptkb:supraventricular_tachycardia hypertension atrial flutter |
| gptkbp:bfsParent |
gptkb:Beta_Blockers
|
| gptkbp:bfsLayer |
8
|